We are monitoring the impact of COVID-19 on Europe Rhinoconjunctivitis Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5328
Share on
Share on

Europe Rhinoconjunctivitis Market Research Report - Segmented By Treatment & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 5328
Pages: 145

Europe Rhinoconjunctivitis Market Size & Growth (2019 – 2024):

As Per the Report, the Size of the Europe Rhinoconjunctivitis Market is valued at USD xx Million in 2019 and is poised to reach USD xx Million by 2024, increasing at a CAGR of xx.x% during the forecast period 2019-2024.

Rhinoconjunctivitis refers to a medical condition which is a combination of rhinitis and conjunctivitis and is one of the most common allergic reactions worldwide. It is an inflammatory disorder that affects nasal and conjunctival mucosa and is caused due to result of hypersensitive immune response. Sneezing, watery mucus, itchy nose, and nasal congestion, as well as conjunctivitis which include burning sensation, tears and redness of eyes are some of the common symptoms of Rhinoconjunctivitis. Poor sleep, irritability and fatigue are also some of the symptoms. According to an article published in Journal of Allergy and Therapy, allergic rhinitis is one of the most common reasons for hospital visits due to allergies.

Increasing awareness about Rhinoconjunctivitis is expected to be the major growth factor during the forecast period. Also improving medical infrastructure, increasing spending on healthcare and increasing number of pharmaceutical players involved in R&D in developing nations is expected to boost this industry.

According to an article published in World Allergy Organizations Journal in 2013, more than 5 million in UK suffered from asthma. Also according to a report published by European Environment and Health Information System, increasing incidences of rhinoconjunctivitis were observed in Poland, Romania and the Russia Federation.

Europe Rhinoconjunctivitis Market has been segmented and sub-segmented into the following categories

  • By Treatment: Decongestants, Mast-Cell Stabilizers, Antihistamines, Nonsteroidal Anti-Inflammatory Drugs, Intranasal Corticosteroids.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

Promising Companies dominating the Europe Rhinoconjunctivitis Market Profiled in the Report are Johnson & Johnson Inc., Merck & Co., Inc., GlaxoSmithKline, Sanofi Adiga Life Sciences Inc.,

1. Introduction       

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                 

                2.1 Introduction     

                2.2 Research Phases                      

      2.2.1 Secondary Research           

      2.2.2 Primary Research 

      2.2.3 Econometric Modelling      

      2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline

3. Overview             

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

                4.1 Market Drivers

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market    

5. Market Segmentation                    

                5.1 Treatment                  

      5.1.1 Introduction           

      5.1.2 Decongestants      

      5.1.3 Mast-Cell Stabilizers            

      5.1.4 Antihistamines      

      5.1.5 Nonsteroidal Anti-Inflammatory Drugs       

      5.1.6 Intranasal Corticosteroids 

      5.1.7  Y-o-Y Growth Analysis, By Treatment         

      5.1.8  Market Attractiveness Analysis, By Treatment       

      5.1.9  Market Share Analysis, By Treatment        

6. Geographical Analysis                    

                6.1 Introduction     

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Treatment

      6.1.4  Market Attractiveness Analysis     

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Treatment

      6.1.5  Market Share Analysis      

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Treatment

                6.2 U.K                 

                6.3 Spain   

                6.4 Germany                     

                6.5 Italy     

                6.6 France

                6.7 Rest of Europe

7. Strategic Analysis             

                7.1 PESTLE analysis                         

      7.1.1 Political     

      7.1.2 Economic 

      7.1.3 Social         

      7.1.4 Technological         

      7.1.5 Legal          

      7.1.6 Environmental       

                7.2 Porter’s Five analysis    

      7.2.1 Bargaining Power of Suppliers        

      7.2.2 Bargaining Power of Consumers    

      7.2.3 Threat of New Entrants     

      7.2.4 Threat of Substitute Products and Services              

      7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis              

                8.1 Johnson & Johnson Inc.                        

      8.1.1 Overview 

      8.1.2 Product Analysis   

      8.1.3 Financial analysis  

      8.1.4 Recent Developments       

      8.1.5 SWOT analysis       

      8.1.6 Analyst View          

                8.2 GlaxoSmithKline                       

                8.3 Sanofi 

                8.4 Merck & Co., Inc.                     

                8.5 HAL Allergy                 

                8.6 Stallergens S.A.                         

                8.7 ALK-Abello A/S                         

                8.8 BioTech Tools s.a.                    

                8.9 Lofarma S.p.A.

                8.10  Adiga Life Sciences Inc.                      

9. Competitive Landscape                 

                9.1 Market share analysis  

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                 

                a) List of Tables                

                b) List of Figures    

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Rhinoconjunctivitis Market By Treatment, From 2019-2024 ( USD Million )
  2. Europe  Decongestants Market By Region, From 2019-2024 ( USD Million )
  3. Europe Mast-Cell Stabilizers Market By Region, From 2019-2024 ( USD Million )
  4. Europe Antihistamines Market By Region, From 2019-2024 ( USD Million )
  5. Europe Nonsteroidal Anti-Inflammatory Drugs Market By Region, From 2019-2024 ( USD Million )
  6. Europe Intranasal Corticosteroids Market By Region, From 2019-2024 ( USD Million )
  7. U.K. Rhinoconjunctivitis Market By Treatment, From 2019-2024 ( USD Million )
  8. Germany Rhinoconjunctivitis Market By Treatment, From 2019-2024 ( USD Million )
  9. France Rhinoconjunctivitis Market By Treatment, From 2019-2024 ( USD Million )
  10. Italy Rhinoconjunctivitis Market By Treatment, From 2019-2024 ( USD Million )
  11. Spain Rhinoconjunctivitis Market By Treatment, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample